PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Sanofi (SAN.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0000120578
SectorHealthcare
IndustryDrug Manufacturers—General

Highlights

Market Cap€110.66B
EPS€4.30
PE Ratio20.62
PEG Ratio0.86
Revenue (TTM)€46.03B
Gross Profit (TTM)€31.70B
EBITDA (TTM)€12.52B
Year Range€80.60 - €104.32
Target Price€103.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with SAN.PA

Sanofi

Popular comparisons: SAN.PA vs. VOO, SAN.PA vs. GSK, SAN.PA vs. TTE, SAN.PA vs. UHS, SAN.PA vs. SPY, SAN.PA vs. SC0T.DE

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Sanofi, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


500.00%1,000.00%1,500.00%2,000.00%2,500.00%OctoberNovemberDecember2024FebruaryMarch
2,245.48%
369.03%
SAN.PA (Sanofi)
Benchmark (^GSPC)

S&P 500

Returns By Period

Sanofi had a return of 1.34% year-to-date (YTD) and -6.58% in the last 12 months. Over the past 10 years, Sanofi had an annualized return of 5.72%, while the S&P 500 had an annualized return of 10.89%, indicating that Sanofi did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date1.34%10.16%
1 month2.40%3.47%
6 months-9.73%22.20%
1 year-6.58%30.45%
5 years (annualized)6.83%13.16%
10 years (annualized)5.72%10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.01%-5.86%
20231.60%2.88%-15.55%-0.28%5.03%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Sanofi (SAN.PA) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
SAN.PA
Sanofi
-0.21
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Sanofi Sharpe ratio is -0.21. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00OctoberNovemberDecember2024FebruaryMarch
-0.21
2.88
SAN.PA (Sanofi)
Benchmark (^GSPC)

Dividends

Dividend History

Sanofi granted a 3.91% dividend yield in the last twelve months. The annual payout for that period amounted to €3.56 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€3.56€3.56€3.33€3.20€3.15€3.07€3.03€2.96€2.93€2.85€2.80€2.77

Dividend yield

3.91%3.97%3.71%3.63%4.02%3.44%4.03%4.14%3.83%3.65%3.72%3.61%

Monthly Dividends

The table displays the monthly dividend distributions for Sanofi. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024€0.00€0.00
2023€0.00€0.00€0.00€0.00€3.56€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00€0.00€0.00€3.33€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2021€0.00€0.00€0.00€0.00€3.20€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2020€0.00€0.00€0.00€0.00€3.15€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2019€0.00€0.00€0.00€0.00€3.07€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2018€0.00€0.00€0.00€0.00€3.03€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2017€0.00€0.00€0.00€0.00€2.96€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2016€0.00€0.00€0.00€0.00€2.93€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2015€0.00€0.00€0.00€0.00€2.85€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2014€0.00€0.00€0.00€0.00€2.80€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2013€2.77€0.00€0.00€0.00€0.00€0.00€0.00€0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%3.9%
Sanofi has a dividend yield of 3.91%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%82.8%
Sanofi has a payout ratio of 82.79%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-20.00%-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-12.52%
0
SAN.PA (Sanofi)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Sanofi. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sanofi was 50.84%, occurring on Feb 13, 2003. Recovery took 2405 trading sessions.

The current Sanofi drawdown is 12.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-50.84%Dec 28, 2001287Feb 13, 20032405Jul 2, 20122692
-33.16%Aug 6, 2015134Feb 11, 2016980Dec 10, 20191114
-32.71%Mar 5, 1992571Jun 21, 1994268Jul 25, 1995839
-26.42%Aug 1, 199762Oct 28, 199742Dec 30, 1997104
-25.34%May 26, 202288Sep 26, 2022148Apr 25, 2023236

Volatility

Volatility Chart

The current Sanofi volatility is 3.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%OctoberNovemberDecember2024FebruaryMarch
3.61%
2.80%
SAN.PA (Sanofi)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sanofi over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items